The founding team

The Spatial Transcriptomics technology was originally developed at Science for Life Laboratory in Stockholm, Sweden
as a joint project between two of Sweden’s leading universities, Karolinska Institutet (KI) and the Royal Institute of Technology (KTH).

Jonas Frisén, Chairman

is the Tobias Foundation Professor of Stem Cell Research at the Department of Cell and Molecular Biology, Karolinska Institutet, since 2001. Jonas Frisén is internationally recognized for his studies of stem cells in adult organs. He has received several prestigious awards, was an advisor to the Swedish Government on research and is a member of the Nobel assembly at the Karolinska Institute. He was a founder of NeuroNova AB, a biotech company, which initiated clinical studies with two new pharmaceuticals developed by the company for ALS and Parkinson’s disease, respectively, before being acquired by Newron Pharmaceuticals in 2012.

Joakim Lundeberg, Director

heads the division of Gene Technology, part of the School of Biotechnology, KTH and has broad competence in technology development with previous experience of innovation. His research group is since May 2010 located at the Science for Life Laboratory (SciLifeLab). This center is devoted to high-throughput biology with combined resources in technology, bioinformatics and biological samples. Prof Lundeberg heads the Genomics platform and SciLifeLab is among the major sequencing sites in Europe and is host for the national platform in MPS.

Patrik Ståhl, Director

is a group leader at SciLifeLab. Patrik is an internationally recognized researcher within the genomics field. He has former experience from successful technology innovation and spin off companies.

Florian Baumgartner, Interim CEO

has experience of working in different European neuroscience and genomics research groups. He was an early employee of the company and has been extensively involved in product R&D and commercialisation.